USDA, KEN HAMMOND
Selections from The Scientist’s reading list:
- More than 20 of 774 US Food and Drug Administration–approved drugs screened by researchers at the University of Texas Medical Branch in Galveston and their colleagues showed some anti-Zika activities, the team reported last week (July 28) in Cell Host & Microbe. “The search for something that will work against Zika virus infection is so urgent that it makes sense to try existing drugs,” Lenore Pereira of the University of California, San Francisco, who was not involved with the work told STAT News. Last month, scientists in Brazil published a preprint showing that sofosbuvir, a drug approved for the treatment of hepatitis C, shows inbhits the Zika virus in vitro, and in May, another team also published a preprint suggesting that the antimalarial drug chloroquine may similarly help fight the infection.
- Animal studies are often too small...
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
